1. Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.
- Author
-
Makarova NU, Pokrowsky VV, Kravchenko AV, Serebrovskaya LV, James MJ, McNeil MM, Lasker BA, Warnock DW, and Reiss E
- Subjects
- AIDS-Related Opportunistic Infections microbiology, Adolescent, Adult, Candida albicans classification, Candida albicans drug effects, Candida albicans genetics, Candida albicans isolation & purification, Candidiasis, Oral microbiology, Child, Child, Preschool, Drug Resistance, Fungal, Female, Genotype, Humans, Infant, Male, Moscow, Pharyngeal Diseases complications, Pharyngeal Diseases drug therapy, Pharyngeal Diseases microbiology, AIDS-Related Opportunistic Infections drug therapy, Antifungal Agents pharmacology, Candidiasis, Oral complications, Candidiasis, Oral drug therapy, Fluconazole pharmacology
- Abstract
Nineteen oropharyngeal Candida albicans isolates from six children and seven adults living with AIDS at the Russia AIDS Centre, Moscow, from 1990 to 1998 were selected for molecular typing. Two fluconazole-resistant C. albicans genotypes were identified from a child who contracted human immunodeficiency virus infection during the Elista Hospital outbreak in the Kalmyk Republic in 1989. Highly related strains were observed 4 years later in the oral lesions and colonization of two patients and a health care worker. There may be a tendency for persons who are living with AIDS in a long-term care facility and who receive fluconazole therapy for oropharyngeal candidiasis to harbor and spread fluconazole-resistant C. albicans strains.
- Published
- 2003
- Full Text
- View/download PDF